Next-Gen Sequencing testing identified rare ALK fusion variant — Mum is in full remission!
"Our local hospital initially suggested palliative chemo with poor prognosis. MedSuggest’s oncology counselor strongly urged comprehensive genomic profiling (CGP). Dr. Sajjan identified an EML4-ALK fusion. My mother was placed on targeted oral Alectinib capsules. Within 12 weeks, the lung mass shrank by 85% with zero hair loss or nausea. She is actively walking in the garden every morning."